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Abstract 
Abstract 
The objective of this work is to develop polymer nanofibrous membranes 
capable of localized and controlled release of the Gentamicin Sulfate (GS) antibiotic. It 
is intended that these systems may be implanted during orthopedic surgery, in order to 
prevent or treat the possible development of bone infection in the post-surgery period. 
The main objective behind localized controlled release of drugs is to develop 
drug delivery systems that have the ability to control the concentration of a drug 
available in the organism in space and time. Most of the developed systems of this kind 
have a polymer base, which is due to the variety of chemical, physical and biological 
properties exhibited by these materials, as well as their ease of production. One method 
for the processing of polymers that is considered attractive for the development of drug 
delivery systems is electrospinning, a technique that allows for the production of 
polymer fibers with diameters from a few micrometers to hundreds of nanometers. 
These structures present a high surface area to volume ratio, which is favorable for the 
incorporation and release of drugs. On the other hand this characteristic also favors a 
fast and extensive release of the incorporated drug, which might be undesirable for 
certain types of therapy. This problem is exacerbated when the drug to be incorporated 
is hydrophilic, as is the case for Gentamicin Sulfate. One possible solution for this 
problem comes in the shape of mesoporous silica nanoparticles (MSN’s), a much 
investigated material for immobilization and release of drugs. 
Therefore, in an attempt to obtain a more controlled release of GS over a 
relatively long period of time, in this work GS was immobilized in MSN’s. These 
particles were then dispersed in a polymer solution which was later electrospun, 
resulting in the incorporation of GS loaded MSN in the electrospun fibers. The polymer 
materials used were poly(lactic acid) PLA and poly(lactic co-glycolic acid) PLGA, 
mixed in different proportions. For comparison, membranes where GS was directly 
dispersed were also made, as well as membranes where half the GS was freely dispersed 
and half was encapsulated in MSN’s. 
The MSN’s – before and after the GS loading - were physically characterized by 
way of nitrogen adsorption/desorption measurements, which allowed for the 
determination of the specific area, pore volume and average pore size. Additionally, the 
quantification of the immobilized GS in the nanoparticles was determined by way of 
thermogravimetric analysis, having obtained a loading of 30% (w/w). The nanofibrous 
membranes were characterized by Scanning Electron Microscopy (SEM), water contact 
angle determination, in vitro release and microbiological tests. 
The in vitro release tests showed that the membranes that possessed GS loaded 
MSN’s presented a more controlled and prolonged release of the drug, in comparison 
with the ones with free GS dispersion. The polymer composition was also shown to 
affect the release kinetics, especially on the membranes with MSN’s. Additionally the 
microbiological tests proved that the GS kept its antibiotic capabilities even after being 
subjected to several processes like encapsulation into MSN’s and later electrospinning. 
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Resumo 
Resumo  
Este trabalho tem como objectivo o desenvolvimento de membranas 
nanofibrosas de base polimérica capazes de actuar como um sistema de libertação 
controlada e localizada do antibiótico sulfato de gentamicina (GS). Pretende-se que 
estes sistemas possam ser implantados aquando de uma cirurgia ortopédica, de forma a 
prevenir ou tratar o desenvolvimento de uma eventual infecção óssea no período pós-
cirurgico. 
A libertação controlada e localizada de fármacos tem como objectivo 
desenvolver sistemas de entrega de fármacos que possuam a capacidade de controlar, 
temporal e espacialmente, a concentração de fármaco disponível no organismo. A 
maioria dos sistemas de libertação controlada (SLC) desenvolvidos é de base 
polimérica, isto é devido à variedade de propriedades químicas, físicas e biológicas 
exibidas por este tipo de materiais  e à facilidade do seu processamento. Um método de 
processamento de polímeros considerado bastante atraente para a preparação de SLC  é  
a electrofiação, uma técnica que permite produzir fibras de base polimérica com 
diâmetros desde alguns micrómetros até algumas centenas de nanómetros. Estas 
estruturas apresentam uma elevada relação de área superficial por volume, o que é 
favorável à incorporação e libertação de fármacos. Por outro lado esta característica 
também favorece uma libertação inicial muito rápida e extensa do fármaco incorporado, 
o que pode não ser desejável para alguns tipos de terapia. Este problema é mais 
acentuado quando o fármaco que se pretende encapsular é hidrofílico, como é o caso do 
antibiótico sulfato de gentamicina. Uma possível solução para este problema vem na 
forma de nanopartículas de sílica mesoporosa (MSN’s), um material muito investigado 
para a imobilização e libertação de fármacos.  
Assim, e numa tentativa de obter membranas  nanofibrosas com uma libertação  
de GS de forma mais controlada e por intervalo  de tempo relativamente longo, neste 
trabalho imobilizou-se GS em nanopartículas de silíca mesoporosa. Estas partículas 
foram então dispersas numa solução polimérica que posteriormente foi sujeita a 
electrofiação, obtendo-se dessa forma a incorporação das MSN’s carregadas com a GS 
nas nanofibras produzidas. Como material poliméricos utilizou-se os polímeros 
poli(ácido láctico) PLA e poli(ácido láctico-co-glicólico) PLGA, misturados em 
diferentes proporções. Para comparação, preparam-se também membranas onde o 
antibiótico foi directamente disperso na solução polimérica, e membranas em que 
metade da GS incorporada se encontrava imobilizada nas MSN e a outra metade na 
forma livre. 
As MSN’s- antes e depois do carregamento com GS- foram caracterizadas do 
ponto de vista físico através de medidas de adsorção/desorção de azoto, o que permitiu a 
determinação da área específica, volume de poro e tamanho médio de poro das 
partículas. Adicionalmente, a  quantificação da GS  imobilizada nas nanopartículas foi 
determinada por meio de análises termogravimétricas, tendo-se obtido uma percentagem 
de carregamento de 30% (p/p). As membranas nanofibrosas produzidas foram 
caracterizadas por SEM, determinação de ângulos de contacto com a água, testes de 
libertação in vitro e testes microbiológicos. 
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Os resultados dos testes de libertação in vitro demonstraram que as membranas 
nanofibrosas com a GS imobilizada nas MSN apresentavam uma libertação mais 
controlada e prolongada do antibiótico, em comparação com as membranas onde a GS 
se encontrava na forma livre. Também se verificou que a composição polimérica da 
membrana afecta a cinética de libertação do antibiótico, especialmente nas membranas 
com MSN. Adicionalmente os testes microbiológicos provaram  que a GS manteve a 
sua capacidade antibacteriana mesmo após ter sido sujeita a vários processos como a 
encapsulação em MSN’s e posteriormente a electrospinning. 
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Chapter 1 
Introduction 
1 Introduction 
 
1.1 Motivation 
Drug administration is a key part of medical treatment, and therefore the need for 
constant development of drugs and their delivery is ever present. Applications dealing 
with antibiotic delivery in post-surgery scenarios, where prevention of infection onset is 
of the highest priority, present one of the most important therapeutic areas as they deal 
with weakened tissues where infection can easily take a foothold [1]. Thus it is no 
surprise that development of drug delivery in these applications is noticed. 
Out of the developments in this area, controlled localized drug delivery is one of 
the most prominent. These systems are, as the name implies, able to deliver the drug at a 
controlled rate that can be defined according to the biological needs at a given situation. 
This not only reduces the toxicity dangers of drug administration but improves the 
therapeutic effectiveness as well due to a tighter dose control [2]. 
Controlled drug delivery requires the use of a vehicle, that is to say a base platform 
on which the drug is incorporated and from where it is later released. For this role the 
most common materials used are without doubt polymers. When speaking of polymeric 
based drug delivery systems and their application, one important aspect to take into 
consideration is the method through which they are produced, as it will, in great part, 
determine the structure and key characteristics of the drug delivery system. 
One method with great potential for producing polymeric structures for drug 
delivery applications is electrospinning. This stems from the nanofibrous structure this 
method is able to produce and the high surface area this kind of structure presents. This 
high surface area is attractive when talking about drug delivery applications. Adding to 
this, electrospinning is a simple and versatile method, where a wide variety of polymers 
can be used and where the drugs can be easily incorporated in the polymeric nanofibers. 
Furthermore it is a cost effective method, and able to be scaled up to industrial levels, 
thus attracting more attention from the financial point of view as well [3].  
With all this in mind, the motivation behind this work is to develop, or at least 
provide the beginning for the development, of a membrane with controlled and 
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localized antibiotic delivery capabilities. The intended final use for this membrane is as 
a means to deliver antibiotics on post-ostheosurgery sites, as an easy and effective 
countermeasure for infection of the vulnerable bone tissue. By using GS, an effective 
antibiotic against Staphylococcus aureus one of the most common bacteria behind 
ostheomyelitis [4], in conjunction with electrospinning, this work aims to result in a 
platform that is effective in the prevention of infection as well as being realistically 
feasible on a large scale. 
1.2 Objectives 
The main objectives of this work are: 
- Production of electrospun nanofibrous membranes, based on the biocompatible 
and biodegradable polymers poly(lactic acid) PLA and poly(lactide co-
glycolide) PLGA,  for controlled and localized release of Gentamicin Sulfate 
(GS);  
- Encapsulate GS into mesoporous silica nanofibers, and add them to polymer 
solutions to be electrospun; 
- Determine the structural characteristics of the membranes; 
- Obtain the release profiles for all the membranes; 
- Observe the differences between the release profiles; 
- Verify if the membranes have antibacterial activity. 
1.3 Structure of this work 
This work is comprised of five chapters and is organized as follows. 
Chapter 1 presents a short introduction and motivation for the work, as well as the main 
objectives. A brief summary of the contents is also made. 
Chapter 2 focuses on the theoretical background of the work. The fundamentals of 
controlled drug released as well as electrospinning are presented. This theoretical part is 
meant to familiarize the reader with the two main components of this work, as well as 
show how they come together. 
Chapter 3 comprises the materials and methodology used in the experimental part of the 
work. The techniques used for production of membranes, as well as for analysis of their 
composition are laid out and explained. The methods used for characterization of the 
membranes, from their structure to their drug release effectiveness, are also presented. 
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Chapter 4 is dedicated to the results obtained from the analysis of the membranes, and 
their characteristics, as well as the discussion of those results. By the end of this 
chapter, all the experimental routes will hopefully be understood and supported by hard 
data. 
Chapter 5 marks the end of the work. Here the conclusions taken from the results and 
suggestions for future work are presented. 
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Chapter 2 
Theoretical Background 
2 Theoretical Bac kground 
 
2.1 Controlled drug release 
Localized controlled release of a drug is, as the name implies, the action of 
controlling the release of a drug, both spatially as well as in time. This can be achieved 
by administration of the drug in an appropriate controlled delivery system. The need for 
these systems comes from the fact that through traditional administration of drugs only 
a small fraction of the initial dosage arrives at its intended sites of action and/or 
receptors. In fact, the majority of the administered drug is destroyed while making its 
way towards the target site, by being taken up by other tissues or even by being 
metabolized too quickly in the target tissue, all this results in large quantities of wasted 
drug that end up serving no purpose [5]. 
Another side of the limitations of traditional administration is related to the 
concentration of the drug in the medium. The lack of specificity of the drugs themselves 
usually results in the need for a higher dose, and therefore an increase in the likelihood 
of the occurrence of unwanted side effects. Moreover, the hydrophobic properties of 
some drugs can make the ideal route for their administration unviable, which in turn 
makes achieving their ideal concentration on the target site very difficult. The 
development of controlled drug delivery systems seeks to eliminate, or at least minimize 
all of these issues [6]. 
Developing a system like this means that a number of factors must be taken into 
consideration: 
- The physical, chemical, pharmacokinetic and pharmacodynamic properties of 
the drug; 
- The physiological and biochemical barriers that come with the way for 
administration; 
- The properties of the material to be used, especially its biocompatibility and, of 
course, the way it reacts to and with the drug; 
- Lastly, the methods used in the manufacture of the system itself, as they also 
affect the behavior of the system. 
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2.1.1 Polymer based release systems 
Due to their properties, variety, as well as versatility, polymers present the 
premium choice for the fabrication of a drug delivery system. However, for a long time, 
polymers were mainly used as additives to aid in the solubilization and stabilization of 
drugs, as well as mechanical support for the sustained drug release. 
With the development of newer more advanced methods, the increased 
availability of different monomers previously unavailable, as well as expertise from 
other areas including biochemistry and nanotechnology, all contributed to 
advancements on the polymer area, creating new polymers that possess properties better 
suited for drug delivery applications, overall making them more effective at this role 
[7].  
Nowadays polymers can be found with such specific properties, that the 
selection of the appropriate one for a specific purpose has become an increasingly more 
important and delicate step. However, any polymer to be considered for drug delivery 
applications must have certain basic fundamental characteristics without which their use 
is impossible for these applications. These are of course all the properties regarding 
biological interaction, of which the one that takes most prominence is biocompatibility 
with the tissues with which they will have contact. Also and if the polymer is 
biodegradable, the toxicity of the byproducts of its degradation must also be low. Due to 
the high water content of living tissue, the hydrophilic (or hydrophobic) characteristics 
of a polymer also present an important factor to be taken into consideration. 
Another important factor that must be taken into account is the polymer’s 
biodegradability. A biodegradable polymer is one that suffers chemical degradation 
from being in contact with living tissue, either through hydrolysis or enzymatic action, 
without producing any toxic (or otherwise harmful) biocompatible products, passible to 
be excreted through the natural processes of the body. Some polymers are not 
biodegradable, but bioerodible instead. What makes them different from the 
biodegradable type is that they do not suffer a chemical degradation, they are instead 
dissolved in the physiological medium and can either be excreted or remain in the 
organism. 
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2.1.2 Silica nanoparticles on drug release 
Mesoporous silica nanoparticles are, as the name implies, a type of silica 
nanoparticles with a mesoporous structure, which is to say they possess pores with a 
diameter in the 2 to 50nm range. The beginnings of these nanoparticles date back to the 
early 1990’s, from the discovery of the M41S family of mesoporous materials, and 
since then new mesoporous solids have been developed. Among them are the MSN’s 
which are also part of the same family, and have presented a promising platform for 
drug delivery since then, mainly due to their ordered mesoporous structure, that presents 
good biocompatibility, surface functionality and chemical stability, allowing at the same 
time for the controlled release of a variety of different drugs [6]. 
 
 
Figure 1 –Electron microscope image of mesoporous silica. [8] 
 
In fact silica is present on various living organisms, from single celled ones to 
plants, which helps explain why it presents a high level of biocompatibility, especially 
when compared to metal oxides such as titania and iron oxide, which are also used for 
biomedical purposes. MSN’s are also easily absorbed through endocytosis by living 
cells. Specifically this is due to the presence of silanol groups on the exterior of its 
mesoporous structure, as silanol may have affinity to phospholipids and these are 
actively absorbed by cells. These silanol groups are also responsible for the creation of a 
layer of apatite, similar to natural bone, when in contact with biological fluids, this 
characteristic allows them to be implanted on damaged bone. Also of note is the active 
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surface that MSN’s possess, which allows for the creation of several surface properties 
for them which can be tailored more specifically to some drugs [6, 9]. [6] [9]  
Several studies have shown that smaller sized particles are better suited for drug 
delivery applications, where particles with a size in between 50nm and 300nm can be 
absorbed by living cells without danger of citotoxicity [10, 11]. Other studies also 
showed that particles on the 200nm or smaller size offer the best efficiency, and induce 
endocytosis, while particles on the microscale are more prone to phagocytosis but may 
not even be absorbed at all [12-14]. [10] [11]  [12] [13] [14] 
With this in mind it is clear that the mesoporous structure of MSN’s is an 
attractive choice for drug encapsulation, as its size can be tuned in the 20nm to 500nm 
range in a controlled fashion. Adding to this, the pore size of the MSN’s can also be 
finely tuned in the 2 nm to 6 nm diameter range with a very narrow size distribution. 
Also, these nanoparticles have a very large surface area and pore volume- usually 
around 1cm
3
/g-   which allows for high drug loading capacities [10].  
Another characteristic of MSN’s that plays a role on its drug delivery behavior 
stems from its ceramic nature. Ceramics are notably slower to degrade than other 
materials used for drug delivery, namely polymers, and in fact they may not degrade at 
all. In MSN’s this stems from the strong Si-O bond, which gives it more stability, 
namely added resistance to mechanical stresses and therefore MSN’s are not prone to 
swelling like polymers. It also gives them a higher resistance to pH and temperature 
variations as well as degradation, which removes the need for other mechanical 
stabilization such as covalent linkers. This means that the drug release may be 
prolonged, as smaller quantities of drugs are released as an initial burst. This property is 
decisive for drug delivery processes that are dependent on diffusion, seeing as these are 
controlled through concentration differences of the mediums, and the concentration 
gradients can be kept for longer which of course means that the release window is also 
larger. Due to all of the properties shown, especially the tunable ones, MSN’s can be 
and are applied to the delivery of various drugs. These include antibiotics, anti-
inflamatories, and even chemotherapeutics [6, 13, 14]. [6] [13] [14] 
Due to the nature of this work, the role of MSN’s in the delivery of antibiotics will 
be given some detail. In the administration of antibiotics it is important to have a 
controlled and targeted release on the relevant tissue. This stems from the need to avoid 
possible resistance to the effects as well as have noticeable and adequate therapeutic 
effect. This requires a delicate balance in the quantity of the drug to be delivered into 
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the tissue, because of the adverse effects that can become apparent on the event of a 
dose which is too high, or of course the ineffectiveness of the antibiotic in the event of a 
dose too small. 
2.2 Fundamentals of electrospinning 
In this section the fundamentals of electrospinning are presented, the origins will be 
briefly explained, as well as the technique itself, and of course its applications 
especially in the field of controlled drug delivery. 
2.2.1 Introduction 
Electrospinning is a process for the formation of fibers on the micro and 
nanoscale using electrical forces. 
The roots of electrospinning go back as far as the 17
th
 century, specifically to 
William Gilbert with his work “On the Magnet and Magnetic Bodies and on that Great 
Magnet the Earth” where his observations on the effects of an electric charge on a fluid 
relate the formation of a structure that can be described as a Taylor cone, before the 
term was coined, and the ejection of fluid droplets from it. The term electrospraying 
was given to the phenomenon and was, in the late 19
th
 century, further developed by 
C.V. Boys who named it electrical spraying [15]. Boys used an apparatus described as 
“a small dish, insulated and connected with an electrical machine”, and observed that as 
the liquid reached the edge of the dish, fibers could be drawn from a few different melts 
[16]. 
Even with all these discoveries, it wasn’t until 1934, by the hand of Anton 
Formhals, that successful electrospinning was achieved, Formhals reportedly 
electrospun a cellulose acetate thread from an acetone solution. Studies on the method 
were continued over the subsequent years, until 1964 when Sir Geoffrey Taylor studied 
and published a number of works on the process and developed a mathematical model 
for it, as well as observing and describing his observations on a conical structure that 
was formed when a liquid was subjected to an electrical charge. This structure we know 
nowadays as the Taylor cone, so named in his honor. Following Taylor’s works, a 
number of studies were made on electrospinning, of which one made by the Reneker 
group at the University of Akron deserves special notice, as it demonstrated the 
10 
 
formation of fibers from a number of organic polymers and popularized the term 
electrospinning [15]. 
Since then there has been an increasing number of publications on 
electrospinning, especially since the year 2000, owing to the simplicity, versatility as 
well as potential uses of the technique [17]. 
 
2.2.2 Technique 
When a high voltage of sufficient intensity is applied to a liquid droplet, it 
becomes charged and the electrostatic repulsion is able to counteract the surface tension. 
It is on this event that electrospinning is based [18]. 
Increasing the intensity of the electric field results in the stretching of the surface 
of the drop, which takes a conical shape that, as has been said in the previous section, is 
named the Taylor cone. When the strength of the electrical field surpasses the surface 
tension, a continuous jet of liquid is ejected from the Taylor cone [19, 20]. [19] [20] 
 
 
Figure 2 – Detail of the Taylor cone. [21] 
 
Upon leaving the Taylor cone, the jet of liquid travels through the air and  goes 
through what is called whipping instability, stretching and accelerating towards the 
direction of a grounded collector, as well as drying in flight. This instability is a result 
of small bends that are present on the initial phase of the jet. Because of these bends the 
surface charges on the perimeter of the jet create a dipolar momentum, resulting in a 
torque that bends the jet and continues doing so the further downstream it goes, the jet’s 
diameter is again decreased as the solvents evaporate [22, 23]. When the liquid is a 
polymeric solution with an appropriated viscosity, during the jet trajectory between the 
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Taylor cone and the collector continuous ultrafine polymeric fibers are formed and 
deposited in the ground collector.  These fibers have typical diameters that range from a 
few micrometers to a few hundred nanometers. These fibers, called electropsun fibers, 
have amazing properties deriving from their small diameter as well as high surface to 
mass ratio [18, 24]. [22] [23]  [18] [24] 
 The basic setup of electrospinning is very simple. It is composed of a high-
voltage DC power supply connected to a spinneret (usually a hypodermic needle), a 
counter electrode which serves as the collector for the fibers, and a mechanism (usually 
a syringe pump) that feeds the spinneret with a stream of the polymeric solution [23].  
 
 
Figure 3 – Typical electrospinning setup. [25] 
 
 Due to the way the whole process works, there are a number factors that 
influence the final geometry and morphology of the formed fibers. These aspects are 
related to different parts of the process as a whole, including the properties of the 
polymeric solution itself, such as the viscosity, the polymer molecular weight, 
conductivity, dielectric constant and surface tension. Other factors include the flow rate, 
distance from the needle to the collector, and the design of the needle as well as the 
collector itself. Aside from these, ambient aspects such as temperature and particularly 
humidity also affect the process, and must be monitored and controlled as best as 
possible [23, 26]. [23] [26] 
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2.2.3 Applications of electrospinning in drug delivery 
The unique properties exhibited by the electrospun fibers, allied with the 
versatility and simplicity of the electrospinning technique itself, makes electrospun 
materials   attractive for various applications, from textile manufacture, filtration and, of 
course, medical applications, where the electrospun fibers are used as scaffolds in the 
engineering of several tissues, like skin, cartilage, blood vessels and even nerves. 
Electrospinning also finds use in the area of drug delivery, which will be given special 
attention due to the nature of this work. 
The high surface area to volume ratio present in the fibers manufactured with 
electrospinning makes it a good candidate for drug delivery applications. The already 
mentioned simplicity of the technique as well as the diversity of choice in the materials, 
where biodegradable as well as non biodegradable materials are viable, only make it 
more convenient and therefore attractive for this application. The first report of 
electrospun fibers used as a drug delivery platform dates back to 2002, by the hand of 
Kenawy et al [2], and since then researchers have paid attention to electrospinning as a 
drug delivery platform [26]. 
A wide variety of polymers, and co-polymers have been used for drug delivery 
applications [3]. Among them the most popular ones for this type of application are 
PLA [2, 27, 28], PLGA [29, 30], poly(L-lactide-co-caprolacone) PCLA [23], 
poly(methyl metacrylate) PMMA[1, 4, 29, 31-33], and poly(ethylene glycol) PEG [27], 
which have been featured in a number of studies. In this work PLA and PLGA were 
combined into mixtures with different configurations, explained in the methods 
sections.  [2] [27] [28] [29] [30] [1] [4] [29] [31] [32] [33]  
A few different methods can be used for the incorporation of drugs in the 
electrospun fibers. They include coating, coelectrospinning of the drugs and the fibers 
(also named embedding), and encapsulation by coaxial and emulsion electrospinning. 
The release kinetics of a drug from an electrospun delivery system can be controlled by 
selecting the most adequate polymer(s) and solvents to use, selecting a specific loading 
method, as well as by manipulating the operational variables of electrospinning 
[26, 34]. [26] [34] 
The coating method, as the name implies, consists on adsorbing or chemically 
attaching the drug molecules directly onto the surface of the formed fibers. In the co-
electropinning, method the drugs are dissolved in the polymer solution and are then 
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electrospun along with the polymer itself. When it isn’t possible to find a solvent or 
mixture of solvents that can dissolve both the polymer and the drug, the drug particles 
can be simply dispersed in the polymer solution. 
The co-electrospinning method presents the advantage of being able to create drug 
loaded polymeric fibers in one single step, and thus being simpler than the coating 
method, as well as resulting in having the drug embedded in the fibers [35]. The release 
of the drug occurs via diffusion, or sometimes by diffusion coupled with the 
degradation of the material when working with biodegradable materials. This means of 
course that the degradation of the polymer plays a role on the release rate, and therefore 
by selecting the chemical composition of the polymers the release rate can be 
controlled.  
The encapsulation form of drug loading is usually used for the incorporation of 
macromolecules into electrospun fibers. Two methods have been successfully 
developed: 
The coaxial electrospinning, that involves the use of two (or more) coaxial nozzles, 
and the emulsion electrospinning, which involves the electrospinning of polymeric 
emulsions using a single nozzle. Both methods produce core-shell structured 
electrospun fibers where the drug is encapsulated in the core and isolated from the 
release environment by a polymeric shell. This means that, theoretically, these methods 
can reduce the initial burst release of the drugs [26]. 
In this work the co-electrospinning and encapsulation methods were both used, the 
latter involved the use of mesoporous silica nanoparticles, in conjunction with GS, an 
antibiotic. 
The choice of MSN’s to combine with the electrospun polymers was not a hard one 
to make. Aside from their merits regarding drug delivery, which were explored in the 
controlled release section, MSN’s have been successfully incorporated into electrospun 
polymer nanofibers over the years. Moreover the characteristics and the drug release 
behavior of MSN’s show that they present a good choice for the release of antibiotics 
[28, 30, 36]. [28] [30] [36] 
As mentioned before, the localized release of antibiotics removes the problem of 
over dosage to some extent, seeing as all of the drug dose will be released in situ as 
opposed to dispersed in the whole body and subjected to being absorbed in the wrong 
tissues. It also solves the opposite problem, that of under dosage, because with the 
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release being localized the whole dose will be released into the relevant site. Besides 
these dose related issues, another important aspect of antibiotic administration is related 
to the need for a continued administration, since for antibiotic drugs to be effective the 
dosage must be kept fairly constant throughout a specific period of time. As has been 
shown before MSN’s can lengthen the release window of drugs, reducing the 
occurrence of an initial release burst and spreading out the release in time. In essence 
they can slow the release of the drug and make it so it releases at a more even rate 
through a set period of time, therefore being a good choice for use in the release of 
antibiotics. 
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MSN’s have been proven, as it was stated before, to slow the release rate of drugs 
on controlled release systems, and therefore to lengthen the release window, which was 
one of the main goals of this work. 
 As such, silica nanoparticles were used to encapsulate the GS and afterwards 
electrospun simultaneously with the polymers as they were a part of the solution. The 
Poly(L,D-lactic acid) (PLA) Ingeo
TM
2002D, with a reported average Mw of 
approximately 130,000 g/mol [37] was purchased from NatureWorks (USA). The 
poly(D,L-lactide-co-glycolide)  (PLGA,  L/G 50:50,  ester terminated,  Mw 54,000 - 
69,000) and the mesoporous silica nanoparticles, with an average  particle size of 200 
nm and average pore size of 4 nm  were bought from Sigma-Adrich. Gentamicin sulfate 
salt (potency ≥ 590 µg gentamicin base per mg) was purchased from Alfa Aeaser. Other 
reagents, namely, o-phthalaldehyde, chloroform, N,N-dimethylformamide (DMF),  
isopropanol, and 2-mercaptoethanol  were all of analytical grade and were obtained 
from several suppliers. 
3.1 Loading of GS into MSN’s 
In order to have GS loaded into the MSN’s, 500 mg of MSN’s were dispersed in 
5ml of GS aqueous solution (50mg/ml) and left under magnetic agitation overnight. 
Afterwards, the suspension was centrifuged, the aqueous phase was discarded, and the 
isolated drug loaded MSN’s were freeze-dried.  
3.2 Preparation of polymer mixtures 
Both PLA and PLGA were used in all formulations, although in different 
proportions. The PLA/PLGA proportions used, in weight, were of 3:1, 1:1 and 1:3, 
designated here as 75PLA/25PLGA, 50PLA/50PLGA, 25PLA/75PLGA. In all 
mixtures, the total polymer weight was of 1g.  The polymers were dissolved in a 
mixture of chloroform and DMF, where the quantity of DMF was always a third of the 
quantity of chloroform.  
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The GS was incorporated in the mixtures by the dispersion of a certain quantity of 
GS loaded MSN’s in the polymeric solutions (mixtures 75PLA/25PLGA-Si, 
50PLA/50PLGA-Si and 25PLA/75PLA-Si) or, alternatively, by the direct dispersion of 
the drug into the polymeric solutions (75PLA/25PLGA, 50PLA/50PLGA, 
25PLA/75PLA). In the last two formulations (50PLA/50PLGA-Si-5% and 
50PLA/50PLGA-Si-15%) half of the added GS was dispersed in the form of “free” GS 
and the other half loaded in the MSN’s. 
The composition of all the mixtures used to fabricate the electrospun materials are 
resumed in Table 1. 
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Table 1 – Composition of the mixtures subjected to electrospinning. 
Mixture 
Polymer 
Weight (g) 
Solvent 
volume* 
(ml) 
GS (mg) 
GS loaded 
MSN’s 
(mg) 
% GS
# 
75PLA/25PLGA 
0,75 PLA+ 
0,25 PLGA 
10 50 - 5 
50PLA/50PLGA 
0,5 PLA + 
0,5 PLGA 
8 50 - 5 
25PLA/75PLGA 
0,25 PLA+ 
0,75 PLGA 
7 50 - 5 
75PLA/25PLGA-
Si 
0,75 PLA+ 
0,25 PLGA 
10 - 125 3,8 
50PLA/50PLGA-
Si 
0,5 PLA + 
0,5 PLGA 
8 - 125 3,8 
25PLA/75PLGA-
Si 
0,25 PLA + 
0,75 PLGA 
7 - 125 3,8 
50PLA/50PLGA-
Si-5% 
0,5 PLA + 
0,5 PLGA 
8 25 84 5 
50PLA/50PLGA-
Si-15% 
0,5 PLA + 
0,5 PLGA 
8 75 250 15 
* Mixture of chloroform and DMF, 3:1 (v/v) 
#  Relatively to the polymer weight (1 g) and considering a  GS loading of 30% (w/w)  
in the GS loaded MSN’s. 
3.3 Fabrication of the drug loaded electrospun materials 
The electrospinning setup used in this work was of a very simple design. It used 
a NE-1000 Multiphaser syringe pump, on which a 10ml syringe was mounted. The 
syringe was connected to a metallic needle through a small diameter tube. The needle 
was mounted on a simple wood support, and was connected to a high-voltage power 
supplier (SL 10W-300W, Spellman) by a crocodile. The collector consisted of a flat 
square surface, grounded through a wire connected underneath it, and covered in tin foil 
at the times when electrospinning was conducted, as observable on Figure 4.  
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Figure 4 – Electrospinning setup used for this work, the power source can be seen on the left. 
 
When conducting electrospinning the first step was to empty the needle and the 
tube that connected it to the syringe of air, to accomplish this the high-voltage supply 
was turned off and the syringe pump was set to a very high rate (this rate varied but was 
always set into the tens of ml/h). Once polymer solution began to drip from the needle 
into the collector, on which a small scrap of tinfoil was set, the pump was stopped the 
tinfoil scrap removed and the electrospinning proper could now take place. Afterwards 
the power supply was turned on (meaning a much higher care was now required) and 
usually set to 15kV, while the syringe pump was typically set to a rate of 2ml/h. 
Notable exceptions to these settings were the solutions that were electrospun on 
days of high air humidity, which required a higher voltage setting of 17kV-18kV, and a 
lower pumping rate, usually reduced to 1,5ml/h. The last batch of polymer solutions 
were electrospun with 14kV and 2,5ml/h settings, the latter aimed at speeding up the 
process.  
3.4 In vitro release tests 
To observe the release profiles of the developed membranes, in vitro release tests 
were performed. With this purpose, rectangular pieces were cut out of the membranes 
and put in a phosphate buffer saline (PBS, pH= 7,4) medium, in an incubator which was 
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set to 37ºC. At predetermined periods of time, the release medium was removed and 
replenished with an equal amount of fresh PBS. 
Samples of the fluid medium were taken on intervals that were the same for all 
tests. Several samples were taken on the first day, then every 24h for a week and every 
48h for the following two weeks. Once this time period was finished, and all the 
samples had been taken, the membrane pieces that were in the release medium were 
dissolved in chloroform. The resulting solution was mixed with 3ml of PBS solution, 
centrifuged and, once the centrifugation was complete, the supernatant (aqueous phase) 
was carefully taken and put into vials. This process was repeated twice more for all the 
samples. This last step was done with the objective of extracting the GS that was still 
left in the membranes after the release time. 
3.5 Quantification of GS by a UV/VIS spectrophotometric method 
The GS in the samples taken during the in vitro release tests was quantified by a 
spectrophotometric method using a UV/VIS JASCO 550 spectrophotometer. Since GS 
does not absorb light in the visible (VIS) or ultra-violet (UV) region, an indirect method 
was used, that involves the reaction of GS with the UV absorbing reagent ortho-
phtalaldehyde (OPA) [38]. 
First, an OPA solution, here designated by OPA reagent, was prepared by mixing: 
- 0,42g of ortho-phtalaldehyde; 
- 10 ml of methanol; 
- 90ml of an aqueous solution of sodium borate 0,04M; 
- 0,5ml of mercaptoethanol. 
 
The reagent must be left to stir for 24h in the dark, as it is sensitive to light and it is 
also only viable for three days, after which it no longer produces the intended reaction. 
Once these 24h have passed, the samples could be prepared for the analysis in the 
spectrophotometer. The samples were prepared by mixing, directly in the plastic 
couvettes, the GS samples, the OPA reagent, and isopropyl alcohol, all of them in equal 
amounts (800 μL). The mixture was then allowed to react at room temperature for 30 
minutes, and afterward the absorbance was registered at the wavelength of 332 nm. 
Standard gentamicin solutions with concentrations between 10 and 100 µg/mg, treated 
the same way, were used to construct a calibration curve. 
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As stated above, the use of a spectrophotometer produces absorption values on a 
given wavelength. The absorption values can be related to GS concentration in the 
solutions by the Beer-Lambert law. 
The Beer Lambert law is a mathematical relation that correlates the attenuation 
of light through a material and the same material’s characteristics. The law states that 
the absorbance and the concentration of a sample are linearly related to one another. It is 
written as: 
𝐴 =  𝜀𝑙𝑐 
Where: 
- ε is the absorption coefficient, units: L.mol-1.cm-1; 
- l is the path length, units: cm; 
- c is the concentration of the sample, units: mol.L-1. 
 
The standard spectrophotometer uses couvettes with a width of 1cm, and in fact it is 
also the case for the couvettes used in this work, and therefore this factor can be 
omitted. Seeing as ε is a constant specific to the material, and therefore known, from the 
value of absorbance or concentration the other value can easily be obtained. 
As mentioned, in this work, five solutions were prepared parallel to the release 
samples taken before. These solutions were simply GS dissolved in a PBS medium, at 
different known concentrations, the absorbance values obtained for these solutions were 
used to construct a calibration curve. The correspondent linear regression provided the 
slope value that allowed the calculation of the concentration values of the samples that 
were tested. 
Once the concentrations of the release samples were ascertained, it became easy to 
obtain the values for the quantities of GS released from the samples, as well as the 
quantities of the residue that was left still in the polymer membrane. These values then 
allowed for the construction of release profiles. 
3.6 MSN characterization 
To characterize the MSN’s two methods were used, thermogravimetric analysis 
(TGA), and nitrogen adsorption/desorption. TGA allowed to ascertain the drug loading 
of the MSN’s, while with the nitrogen adsorption/desorption analysis the surface 
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characteristics of the MSN’s, namely the pore diameter distribution and pore volumes 
with and without GS loading were determined. 
3.6.1 Thermogravimetric analysis 
The weight loss in function of temperature for pure GS, pure silica MSN’s, and 
GS loaded silica MSN’s, was recorded from room temperature to 1200ºC and at a 
heating rate of 10ºC/minute,  using a simultaneous thermoanalyzer SDT 600 (TA 
Instruments). 
The obtained thermograms were then used to calculate the GS loading into the 
silica MNP’s. 
3.6.2 Nitrogen adsorption/desorption measurements 
The surface area and pores size distribution of the nanoparticles was evaluated by 
nitrogen adsorption/desorption isothermal measurements performed on a Micromeritics 
ASAP 2000 analyzer. The surface areas were calculated based on the Brunauer-
Emmett-Teller (BET) theory, while the pore volume and pore size distributions were 
obtained from the adsorption isotherm branch, using the Barrett-Joyner - Halenda (BJH) 
method. 
3.7 Characterization of electrospun materials 
Similarly to the MSN’s, the electrospun materials also had to be characterized, this 
was done through (SEM) and water contact angle determination. SEM permitted the 
observation of the morphology of the materials, while the water contact angles allowed 
the determination of their hydrophobicity levels. 
3.7.1 Scanning Electron Microscopy 
All of the manufactured membranes were analyzed with SEM, in order to 
observe the morphology of the membranes as well as the way the MSN’S were 
distributed throughout the fibers. Additionally, some membranes were also analyzed 
after being immersed in PBS at 37ºC for a period of 15 days.  
For this analysis, small squares were cut out of the membranes, placed on 
double-sided graphite tape, attached onto a metal support, and sputter-coated with gold. 
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Observations were performed with a JSM-5310 (JEOL, Japan) scanning electron 
microscope.  SEM images were also used to make an assessment of the fibers diameters 
distribution by means of image analysis software (ImageJ). 
3.7.2 Water contact angle determination 
To evaluate the hydrophobicity/hydrophilicity character of the surface of the 
electrospun fiber materials, water contact angles measurements were performed. The 
measurements were made with a Dataphysics OCA-20 contact angle analyzer 
(DataPhysics Instruments, Filderstadt, Germany) using the sessile drop method.  The 
materials were cut into strips attached to a glass slide, and placed in the sample stage. A 
droplet of deionized water (10 µl) was automatically dispersed onto the sample surface 
and its contact angle calculated by the software of the equipment. At least five 
independent measurements were performed for each type of material. 
3.8 Release efficiency 
As stated above, the use of a spectrophotometer produces absorption values on a 
given wavelength. Absorption values on their own do not hold much meaning, and 
therefore must be treated in order to obtain values that do, in this case values of the 
quantity of released GS as well as how much was left in the membrane. This treatment 
is made mathematically and uses the Beer-Lambert law. 
3.9 Antimicrobial activity tests 
Seeing the intended purpose of the membranes is to locally release an antibiotic in 
controlled quantities, it is necessary to verify that when incorporated in the fibers the 
GS keeps it’s antibacterial effectiveness. 
The antibacterial activity of the GS loaded fibers against Staphylococcus aureus 
was determined by a disc diffusion (Kirby Bauer method) assay according to the 
European Committee on Antimicrobial Susceptibility Testing (EUCAST; 
http://www.eucast.org). The S. aureus clinical isolated used was identified as 
susceptible to Gentamicin (results not shown). Briefly, S. aureus was grown overnight 
in Mueller-Hinton plates (Diagnostics Pasteur, France). A bacterial suspension (0.5 
McFarland turbidity) was spread with a swab onto Mueller Hinton petri dishes. The 
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materials were cut in 7 mm-diameter discs and deposited in the centre of each plate. The 
plates were incubated at 35 ºC and, after 24h the inhibitory effect of each disc was 
observed and evaluated by measuring the diameter of the inhibition zones, as observable 
in figure 5. 
 
 
Figure 5 – Method used for the antimicrobial activity test. 
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In this section the results pertaining to the methods listed in the previous section are 
presented, as well as some observations on the immediate analysis of those results. The 
final conclusions to be taken from these results are presented on the section following 
the present one. 
4.1 Nanoparticles physical characterization 
The surface area and pore size of the MSN’s will in great part determine the drug 
loading capacity of the nanoparticles and the drugs release kinetics. For this reason the 
surface area, the pore volume and the distribution of pores sizes of the MSN’s were 
determined by nitrogen adsorption/desorption measurements, for the blank 
nanoparticles and the GS loaded nanoparticles. The results of this analysis are shown on 
figures 6 and 7, as well as on table 2. 
 
Figure 6 – Isothermal graph for nitrogen adsorption/desorption. 
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Figure 7 – Graph for the distribution of pore diameter for the MSN’s. 
 
Table 2 – Nitrogen adsorption/desorption data. 
 SBET (m
2
/g) Vp (cm3/g) Dp (nm) 
MSN’s 763 0,860 3,3 
GS loaded MSN’s 449 0,515 3,4 
 
The table shows that the MSN’s have a high surface area with 763m2/g and 
relatively large pore volume of 0.860cm
3
/g. When loaded with GS particles both these 
values suffer a reduction, this is of course what is expected seeing as the once empty 
pores now contain GS particles that take up space. What is interesting to note is that 
after the GS addition both the volume and the surface area suffer a reduction of just over 
40%, which shows that not even half of the pores’ capacity is taken up by the GS, 
meaning that it could theoretically be possible to load the MSN’s with a much higher 
quantity of GS. The pore diameter change in between the two MSN’s, the GS loaded 
one and the free MSN’s, is a very small difference and is in fact negligible. 
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4.2 Quantification of the GS loaded into the MSN’s 
In the production of the GS loaded fibers, the quantity of GS to be loaded into the 
membrane must be known, as the drug dose is one of the main factors in any drug 
administration. 
Apart from this, in the perspective of the study the quantity of GS to be loaded into 
the fibers must be known to allow for the construction of the release profiles. When 
dealing with direct dispersion of the GS in the polymer solutions this is not an issue, as 
the quantity of GS is known from the start, however this is not the case for the GS 
loaded into the MSN’s. 
When loading the MSN’s with GS the quantity added to the solution is known, 
however how much GS is actually encapsulated into the MSN’s is not, and therefore 
this quantity must be determined. This was done through the use of a thermogravimetric 
analysis, which then allows for the mathematical determination of the quantity of GS 
encapsulated in the MSN’s. 
Figure 8 presents the weight loss profiles in function of temperature- from  
environment temperate to 1200ºC -  of the pure gentamicin sulfate (GS), unloaded 
MSN’s (npSi) and gentamicin loaded MSN’s (npSi-GS).  
 
Figure 8 – TGA graph for GS, MSN’s, and GS loaded MSN’s. 
 
The graph shows that the silica nanoparticles do not lose any mass during the 
course of the whole test, this is due to the inorganic nature of this material. Contrarily, 
the GS thermogram presents two main steps of weight loss: one around 100ºC, 
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attributed to the evaporation of water bound to the antibiotic molecules, and another 
situated between 250 and 350ºC, that can be ascribed to the thermal degradation of the 
drug. After this second step, the weight decreases slowly until only about 25% of the 
initial GS mass is left at 1200ºC. This remaining mass is probably due to inorganic salts 
associated with the drug that didn’t suffer degradation. The main step of weight loss in 
the GS loaded nanoparticles (np-Si-GS) happens in the degradation zone of GS (250-
350º), corresponding to the thermal degradation of the antibiotic immobilized in the 
particles. 
Considering the final weights of the samples and through a mass balance the 
quantity of GS loaded into the nanoparticles was calculated (presented in Annex A). 
The obtained value was 30% (w/w).  
4.3 Membrane structure  
In the following section SEM images of the nanofibers are presented. They allow 
for the observation of the way the fibers are deposited and their orientation, as well as 
their morphology and, when applicable, the way the MSN’s are placed throughout the 
fibers. 
Figures 9 through 11 show pictures with different magnifications of the membranes 
loaded with free GS and composed of 25% PLA and 75% PLGA (Figure 9), 50%PLA 
and 50%PLGA (Figure 10) and 75%PLA and 25%PLGA (Figure 11). It is possible to 
observe the disposition of the fibers on the pictures on the left, and on the pictures of the 
right the surface morphology of the nanofibers. In the membranes with equal 
proportions of both polymers and with higher content of PLA a few round polymeric 
structures occur, designated as beads. They are more common on the fibers with more 
PLA. These structures are usually formed due to the polymer composition, more 
specifically to the higher concentration of certain polymers [26]. Such seems to be the 
case for PLA, seeing as the occurrence of beads in the images is concordant with the 
increase of PLA content. 
 
 
29 
 
 
Figure 9 – SEM images for the membrane with 25%PLA content and without addition of MSN’s. 
Magnification: 750x(left), 10000x(right). 
 
 
Figure 10 – SEM images for the membrane with 50%PLA content and without addition of MSN’s. 
Magnification: 750x(left), 10000x(right). 
 
 
Figure 11 – SEM images for the membrane with 75%PLA content and without addition of MSN’s. 
Magnification: 750x(left), 10000x(right). 
 
The average diameters of the fibers, estimated by image analysis, are presented 
in table 3. From the table it is observable that the different polymer compositions result 
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in different fiber diameters. The values that were obtained show that the fibers with 
equal content of both polymers have a larger diameter than the others, while the fibers 
with the highest content of PLA have the smallest. With the addition of MSN’s the 
diameters for all of the membranes increase but the highest diameter is now for the 
25PLA/75PLGA membrane while the smallest remains for the 75PLA/25PLGA fibers. 
It is also apparent that the increase of the diameter is much less pronounced for the 
75PLA/25PLGA which might be related to the way the MSN’s is distributed on these 
fibers, this observation can be made on figure 14. 
 
Table 3 – Average diameter of the fibers. 
  Average fiber diameter (μm) 
  Without MSN 
addition 
With MSN addition 
Membrane 
Composition 
25PLA/75PLGA 1,08 ±0,17 1,68 ±0,16 
50PLA/50PLGA 1,22 ±0,10 1,47 ±0,27 
75PLA/25PLGA 0.90 ±0,10 0,96 ±0,17 
 
As can be seen in the images with higher magnifications, the surfaces of the 
nanofibers are smooth, with no visible pores.  Also, on the surface of the fibers with the 
lowest amount of PLA (Figure 9) it is possible to observe some particles that are 
probably GS particles that were not incorporated inside the fibers. For the other 
compositions these particles were less visible or absent. 
Figures 12 through 14 show the SEM images for the GS-silica loaded 
membranes. As it can clearly be seen the polymer agglomerates are still present for the 
fibers with the higher quantities of PLA. Also, on all of them it is possible to observe 
agglomerates of MSN particles, partially embedded on the fibers.   
The images show that the polymer composition may also influence the 
disposition of the MSN’s on the fibers, as the fibers with higher content of PLA (figure 
14) show the formation of bigger agglomerates of silica nanoparticles. Thus, on the first 
set of images (figure 12) we can see that the MSN’s are more loosely dispersed, while 
on the second case (figure 13) a few larger agglomerates can be seen, and on the last 
case (figure 14) there are less but larger agglomerates of MSN’s. This might relate to 
the differences of release behavior that will be shown later on in this section. 
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While it might be difficult to conclude from observation of the images, the 
values on table 1 indicate that the diameter for these fibers is larger than it was for their 
MSN-less counterparts. This might be due to the presence of the MSN’s inside the 
fibers, which would add volume and size to the fibers. While this is not completely 
obvious from observation of the images they do show that the MSN’s adhere well to the 
polymer fibers and some are partially absorbed into them (observable in figure 13). 
Therefore it is not farfetched to assume that some MSN’s are included inside the fibers 
themselves, and therefore adding to their size. 
 
 
Figure 12 – SEM images for the membrane with 25%PLA content and addition of MSN’s. Magnification: 
750x(left), 10000x(right). 
 
Figure 13 – SEM images for the membrane with 50%PLA content and addition of MSN’s. Magnification: 
750x(left), 10000x(right). 
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Figure 14 – SEM images for the membrane with 75%PLA content and addition of MSN’s. Magnification: 
750x(left), 10000x(right). 
 
The images that follow (figures 15 and 16) are for the membranes with the 
hybrid loading of GS, with both dispersion of free GS and GS loaded MSN’s, and 
fabricated with 50%PLA and 50%PLGA. It is necessary to note the omission of the 
SEM images for the fibers with 10% loading of GS. This is due to the fact that those 
membranes suffered contamination from a source still unknown at the time of the 
elaboration of this work. The contamination only made itself known when the samples 
were being prepared for analysis in the spectrophotometer, regardless, the results from 
their analysis could not be taken into consideration due to this occurrence. 
 
 
Figure 15 – SEM images for the membrane with a hybrid GS load method of 5%. Magnification: 750x(left), 
3500x(right). 
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Figure 16 – SEM images for the membrane with a hybrid GS load method of 15%. Magnification: 750x(left), 
10000x(right). 
 
These membranes are very visually similar to the previous ones, which is of course 
to be expected as there is nothing new in their basic composition. The most notable 
visual difference between these membranes and the ones shown previously is the 
coexistence of what seems to be free GS particles and agglomerates of MSN’s. It can 
easily be seen that, also as expected, in the membrane with 15% GS load there is a 
much larger quantity of agglomerates. In fact the images on the left for both of them 
illustrate this difference well, as on the 15% membrane MSN agglomerates have much 
more pronounced presence than on the 5% one. The free GS is more difficult to spot, 
however it can be seen on the second image for the 5% membrane, a few free GS 
particles are present along with a partially hidden agglomerate of MSN’s.  
The diameters for these fibers were also measured, the 5% load fibers averaged a 
1,05±0,04μm while the 15% load fibers averaged 1,40±0,22μm. These values are 
relatively similar to the ones obtained for the 50/50 fibers with MSN’s, which is to be 
expected considering their similar composition. Also to be expected is the smaller 
diameter of the 5% load fibers when compared to both the 15% load ones as well as the 
original 50/50 fibers with MSN’s, seeing as the 5% load fibers contain a smaller 
quantity of MSN particles. However, the 15% load fibers show a similar diameter to the 
original 50/50 fibers with MSN addition, despite a much larger MSN content. Upon 
observation of the images for both (figures 13 and 16) it can be seen that the 15% load 
fibers show more agglomerates of MSN’s. Therefore it seems that a maximum of 
MSN’s located inside the fibers themselves is reached on both, and thus the excess 
MSN on the 15% load fibers forms the agglomerates. 
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As stated before a set of membranes were left in a PBS medium at 37ºC for two 
weeks, in order to verify the degradation of the membranes with time. The SEM images 
regarding these tests are shown in figures 17 through 19. 
 
 
Figure 17 – SEM images for the membrane with 25%PLA content and addition of MSN’s, after two weeks. 
Magnification: 750x(left), 3500x(right). 
 
 
Figure 18 – SEM images for the membrane with 50%PLA content and addition of MSN’s, after two weeks. 
Magnification: 750x(left), 10000x(right). 
 
Figure 19 – SEM images for the membrane with 75%PLA content and addition of MSN’s, after two weeks. 
Magnification: 750x(left), 10000x(right). 
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After two weeks it can easily be seen that the fibers have suffered degradation, 
however it is also clear that the amount of degradation for each membrane is different. 
Starting with the membrane with 25% PLA content (figure 17), it is clear how 
much the fibers were affected. The first image on the left clearly shows missing 
segments on the fibers. These are likely to be the sites where there were previously 
MSN agglomerates, although they can also simply be broken fibers. On the image on 
the right, the fibers are clearly degraded and their structure has already begun breaking 
down. The second set of images (figure 18) shows that the 50% PLA content fibers did 
not suffer as much degradation as the previous ones, and although on the left missing 
segments on the fibers can be observed they occur much less, and on the right the fibers 
have not degraded as much and agglomerates of MSN’s can still be seen. However if 
one looks closely these agglomerates show spots where MSN’s were likely set. On the 
third and final membrane (Figure 19) the degradation is much less pronounced and the 
fibers themselves show very little signs of it, MSN agglomerates are still present as well 
although the loss of some particles is evident. On the last image on the right the missing 
MSN spots can be easily seen, and present an interesting detail to observe. 
These differences in degradation of the fibers can be related to their composition. 
PLA and PLGA have different degradation times, with the latter degrading faster, and 
the mixture of these two polymers also affects the degradation rate of the fibers. This 
can be attributed to the lower hydrophobicity of PLGA [39]. 
4.4 Water contact angles 
As described on the methods section, an analysis of the water contact angles was 
performed, in order to evaluate the level of hydrophobicity of the membranes’ surface. 
The obtained results are represented in figure 21. Generally, if the water contact angle is 
larger than 90°, the surface can be considered hydrophobic and if the water contact 
angle is smaller than 90°, the surface is considered hydrophilic as can be observed on 
figure 20. 
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Figure 20 – Contact angles relation with hydrophobicity/hydrophilicity. Adapted from [40] 
 
Due to the hydrophobic nature of the polymers used - PLA and PLGA- it was 
expected that the membranes without silica nanoparticles would exhibit a hydrophobic 
behavior. This supposition was confirmed by the obtained contacted angles that varied 
between 132 º and 137º. With the addition of silica nanoparticles, a hydrophilic 
material, the hydrophobicity of the membranes was liable to change. In fact, all 
membranes with silica had slightly inferior contact angles in comparison with the 
membranes with the same composition but without silica. Still, the contact angles 
values - that varied between 115º and 132º - indicate that the membranes with silica 
retain the hydrophobic character of the polymers. This can be justified by the small 
percentage of silica in the nanofibers (around 10% of the polymer weight) and by the 
fact that at least part of the nanoparticles are in the interior of the nanofibers.  
 
 
Figure 21 – Contact angles comparison for each polymer composition. 
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4.5 In vitro release 
As stated on the methods section, in vitro release tests in PBS at 37ºC were 
performed for all the membranes in order to evaluate the GS release profiles. The results 
are presented here, split between membranes with GS dispersed in the polymer solution 
(Figure 22, Table 4), membranes with added npSi-GS (Figure23, Table 5), and finally 
the last batch of membranes with the hybrid load of GS in different quantities (Figure 
24, Table 6). 
 
Table 4 – Release data for the membranes without addition of MSN. 
 Released % GS 
Time 25PLA/75PLGA 50PLA/50PLGA 75PLA/25PLGA 
1h 7,3 ± 2,9 5,5 ± 0,8 8,3 ± 5,1 
8h 34,0 ± 4,5 35,2 ± 2,1 39,4 ± 10,5 
1 day 42,4 ±4,5 46,1 ± 8,2 48,0 ± 12,2 
7 days 62,9 ± 8,2 71,7 ± 9,0 76,8 ± 6,0 
14 days 74,2 ± 13,7 85,0 ± 7,9 89,4 ± 3,9 
18 days 80,2 ± 14,4 93,2 ± 9,0 - 
 
 
 
Figure 22 – Release profiles for the membranes without addition of MSN’s. 
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The GS release profiles from the membranes without MSN’s are very similar for 
all the three polymeric compositions.  All membranes exhibit a burst release in the first 
day, with the release of around 40% of the antibiotic. After this first phase, the 
membranes exhibit a gradual release of the antibiotic until the end of the assay at the 
18
th
 day, when the percentage of GS release reaches a value equal or superior to 80%. 
The GS release profiles from the membranes containing gentamicin loaded 
MSN’s are presented in Figure 23 and Table 5. As it can clearly be observed, the 
addition of MSN’s has resulted on a decrease of the release rate for all the membranes. 
This is especially pronounced for the one with equal quantities of both polymers, as the 
same polymer composition presented one of the higher release rates with no MSN 
addition, and with it presents the lowest with a drop of total GS released of over 50%. 
While the membrane with the least PLA (and the most PLGA) shows the least decrease 
of release rate, as well as released quantity, which is less than a 10% difference for the 
same polymer composition without silica. 
 
Table 5 – Release data for the membranes with addition of MSN’s. 
 Released % GS 
Time 25PLA/75PLGA 50PLA/50PLGA 75PLA/25PLGA 
1h 3,4 2,3 3,2 
8h 29,0 12,9 14,3 
1 day 37,7 15,4 17,5 
7 days 51,9 23,0 28,8 
14 days 60,3 31,0 43,5 
18 days 71,6 39,4 53,1 
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Figure 23 – Release profiles for the membranes with addition of MSN’s. 
 
Unlike with the membranes with no MSN addition, the release profiles are quite 
different among the polymer compositions. This can be related to the degradation rates 
analyzed before, since the membrane that shows the fastest release rate is also the one 
with the fastest degradation. This is to be expected since as the fibers start to degrade, 
the MSN’s (loaded with GS) are released into the medium. At the same time, while the 
50PLA/50PLGA fibers showed higher degradation than the 75PLA/25PLGA ones, they 
also show the slowest release rate. At first glance this might seem strange, however, 
upon observation of figures 18 and 19 it can be seen on figure 18 (50PLA/50PLGA) 
that while the fibers themselves are more degraded than the ones shown on figure 19 
(75PLA/25PLGA), there are less MSN’s missing from its agglomerates, while the 
opposite is apparently true for the 75PLA/25PLGA fibers. 
In Figure 24 and Table 6 are the results for the GS release profiles of the hybrid 
load membranes.  The graph clearly shows that the membrane with the highest quantity 
of GS (15%) has a very high initial release burst, where over 75% of the drug it 
contained was released after just one day, and over 92% after one week, leaving very 
little GS content in the membrane for the last week. This is, however, not unexpected 
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due to the quantity of GS present in these fibers. It is only natural that the higher 
concentration would result in a bigger initial burst and a faster release rate. 
 
Table 6 – Release data for the membranes with hybrid load of GS. 
 Released % GS 
Time 5% GS 15% GS 
1h - 8,1 
8h 9,8 51,9 
1 day 13,4 75,4 
7 days 37,9 92,2 
14 days 53,2 95,7 
18 days 59,2 97,0 
 
 
Figure 24 – Release profiles for the membranes with hybrid GS load. 
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the membrane would have a much wider release window. It is regretful that the 
membrane with 10% GS load suffered contamination and therefore could not be 
included in the release tests, as it could, in principle, show a release profile that would 
fit between the ones presented in the graph, and could have very well presented the best 
solution for the three week window. 
4.6 Antimicrobial activity 
This section shows the results of the antimicrobial tests. As it was described on the 
methods section, 7mm discs were cut from all the samples. However the mass of each 
sample varied by a considerable margin, which is of course partly due to the different 
composition of the membranes, yet it must be noted that the membranes’ density was 
not equal within all of its area, resulting in some parts being denser than others. Besides 
that factor, something that also affected the samples’ final mass was the fact that some 
membranes, specifically the ones with higher quantity of PLGA, tended to stick to the 
tin foil they were deposited on and leave some material on it that was not possible to 
remove without destroying the membranes’ structure. 
The first results shown on table 7 and figure 25 refer to the control membrane. This 
membrane was a 50PLA/50PLGA membrane with no addition of GS in any form. 
 
Table 7 – Results of the antimicrobial test for the control membranes. 
Samples Mass (g) 
Diameter of halo 
(cm) 
Control 
Sample 1 3,28 0 
Sample 2 3,88 0 
 
 
Figure 25 – Antimicrobial activity for the control samples. 
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Through observation of the images it is clear that the membranes themselves 
have no antimicrobial activity whatsoever, as expected, and therefore all the following 
results can be credited solely to the release of GS. 
The results for the GS loaded membranes, without MSN addition are presented 
below on table 8, and figures 26 through 28. 
 
Table 8 – Results of the antimicrobial test for the membranes with no MSN addition. 
Samples Mass(g) 
Diameter of halo 
(cm) 
25PLA/75PLGA 
Sample 1 6,69 3,6-3,7 
Sample 2 6,50 3,6-3,7 
50PLA/50PLGA 
Sample 1 4,41 3,2 
Sample 2 4,95 3,2 
75PLA/25PLGA 
Sample 1 3,58 3,2 
Sample 2 3,72 3,2 
 
As can be seen on the table above the sample masses vary considerably, the 
reasons for which were previously presented. This, in turn, has affected the quantity of 
GS released. 
 
 
Figure 26 – Antimicrobial activity for the 25PLA/75PLGA samples. 
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Figure 27 – Antimicrobial activity for the 50PLA/50PLGA samples. 
 
Figure 28 – Antimicrobial activity for the 75PLA/25PLGA samples. 
 
From observation of the pictures the antibacterial effect can be seen on the 
bacterial population, which conclusively illustrates the presence of GS released by the 
membranes. The effect of the polymer composition on the release kinetics can also be 
observed to an extent, as the samples with the smallest mass, 75PLA/25PLGA, showed 
the same halo diameter as the 50PLA/50PLGA samples and close to the 
25PLA/75PLGA samples, even with the steep difference in mass. This is also 
concordant with the in vitro release results shown before. 
On table 9 the antibiotic results for the membranes with MSN addition are 
shown, the correspondent figures (29 through 31) are presented below the following 
table. 
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Table 9 – Results of the antimicrobial test for the membranes with MSN addition. 
Samples Mass (g) 
Diameter of halo 
(cm) 
25PLA/75PLGA 
with MSN’s 
Sample 1 6,14 3,2 
Sample 2 5,53 3,3 
50PLA/50PLGA 
with MSN’s 
Sample 1 5,35 3,0 
Sample 2 5,43 3,0 
75PLA/25PLGA 
with MSN’s 
Sample 1 7,32 3,2 
Sample 2 7,54 3,1 
 
 
Figure 29 – Antimicrobial activity for the 25PLA/75PLGA samples with MSN’s. 
 
Figure 30 – Antimicrobial activity for the 50PLA/50PLGA samples with MSN’s. 
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Figure 31 – Antimicrobial activity for the 75PLA/25PLGA samples with MSN’s. 
 
Similarly to what has been observed for the previous set of samples a defined 
halo was formed, evidencing the antibacterial effect of the membranes. However what is 
important to note in these results is the halo diameters these samples present which, 
despite the mass difference, are similar to the halo diameters of the previous samples. 
The conjunction of the larger mass with similar halo size indicate the slower release rate 
for these samples, thus supporting the in vitro release test results shown previously. 
The hybrid load membranes were also tested for antibiotic activity. The results 
are shown on table 10 as well as figures 32 and 33, which are presented below. 
 
Table 10 – Results of the antimicrobial test for the membranes with hybrid GS load. 
Samples Mass (g) 
Diameter of halo 
(cm) 
50PLA/50PLGA 
(5% GS content) 
Sample 1 5,51 3,2 
Sample 2 5,55 3,3 
50PLA/50PLGA 
(15% GS content) 
Sample 1 3,74 3,5 
Sample 2 2,86 3,5 
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Figure 32 – Antimicrobial activity for the samples with 5% GS load. 
 
Figure 33 – Antimicrobial activity for the samples with 15% GS load. 
 
As to be expected, the membrane with 15% GS content showed a large halo, the 
second largest in fact, even despite showing small mass values. This concurs with the 
data obtained before, as it was shown that this membrane presented a high initial release 
burst, and after one day over 75,4% of the GS content was released. The sample with 
5% GS content showed similar results to the other MSN loaded samples, much like the 
in vitro release results for the same membrane. 
To illustrate the effect of the contamination on the membrane with the 10% GS 
hybrid load, the antimicrobial test results were performed on it. The results are shown 
on table 11, and the pictures for them are shown on figure 34. 
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Table 11 – Results of the antimicrobial test for the membranes with hybrid GS load. 
Samples Mass (g) 
Diameter of halo 
(cm) 
50PLA/50PLGA 
(10% GS content) 
Sample 1 7,00 0,0 
Sample 2 7,40 1,1 
 
 
Figure 34 – Antimicrobial activity for the samples with 10% GS load. 
 
As made abundantly clear by the results shown, the unknown contamination 
these samples suffered heavily impacted their drug release capabilities. The first sample 
shows no antimicrobial activity whatsoever, while the second sample shows a small 
amount of activity but well below all the previous samples, as well as what would be 
reasonably expectable considering its characteristics. 
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Chapter 5 
Conclusions and Future Work 
5 Conclus ions and Fu ture Work  
 
The GS was successfully loaded into three polymer mixtures of PLA and PLGA in 
different proportions, respectively 3:1, 1:1 and 1:3. The resulting electrospun 
membranes showed a good fibrous structure and a positive incorporation of the GS 
antibiotic. They also showed good drug delivery capabilities, having proven to have the 
ability to release drug in close to biological conditions (37ºC in PBS medium with 
7,4pH). However this release was characterized by a sharp initial burst resulting in a 
very fast release of a high amount of drug. Almost 40% of the total drug was released 
during the first day and close to 80% after just 10 days. 
GS was also successfully immobilized in mesoporous silica nanoparticles, which 
were subsequently mixed into three polymer mixtures of PLA and PLGA in the same 
proportions as the previous mentioned membranes. These membranes showed that the 
MSN’s were well incorporated into the polymer fibers, which were able to hold them in 
agglomerates. These MSN loaded membranes showed a slower release rate, and were 
effective in reducing the initial burst that was present on the membranes without the 
MSN’s. The release rates for these membranes were in general more controlled, 
resulting in much less GS quantity released over the same period of time (18 days). As 
low as 30% of total GS released was observed versus nearly 90% for the membranes 
lacking MSN’s. 
Polymer composition also played an important role on the release kinetics. 
While the differences were small for each polymer composition without MSN’s, with 
their addition the difference in release rate for each polymer composition was evident. 
The 50PLA/50PLGA as well as the 75PLA/25PLGA membranes showed a marked drop 
of release rate with the addition of MSN’s, while the 25PLA/75PLGA membrane 
showed very little difference. These results come from the different rates at which the 
membranes degrade in the medium. The latter membrane shows a much higher degree 
of degradation following three weeks of exposure to the medium, while the other 
membranes degrade at a noticeable slower rate, and while the 50PLA/50PLGA 
membrane is not the slowest to degrade it seems to be able to hold the MSN’s for longer 
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when compared to the 75PLA/25PLGA membrane, which shows very little fiber 
degradation but a higher loss of MSN particles. 
The hybrid loaded membranes also showed release profiles within the expected, 
where the membrane with the highest GS concentration showed the fastest release as 
well as a very sharp initial burst, having released over 90% of its total GS content after 
the 18 days period, while the 5% load membrane showed a much slower release rate 
with a much less pronounced release rate. The 10% membrane suffered contamination 
and therefore produced no results. From the observation of the release profiles of both 
valid hybrid membranes, it is not wrong to assume that the different loads can be used 
for different situations or even different stages of antibiotic therapy. While the initial 
burst of the 15% load membrane can be useful for early stages of therapy, the more 
controlled release of the 5% one may be more useful for later stages of the same 
therapy. 
The antibacterial tests proved that the GS does not lose its antibiotic activity 
after being mixed with the polymers, being encapsulated in the MSN’s and after going 
through electrospinning. When put in contact with the Staphylococcus aureus bacteria 
the membranes showed bactericidal capabilities after an exposure time of 24h, with 
halos forming around the round discs cut from the membranes in the bacterial 
population. Because the exposure time was just 24h the antibacterial halos showed 
similar diameter across all membranes, the only exceptions are for the 25PLA/75PLGA 
membrane with no MSN’s and the 15% hybrid load membrane which showed halos 
notably larger than the others. However the higher antibacterial activity of the 
25PLA/75PLGA membrane is attributed to its much larger mass and not from higher 
release capabilities, also supported by the release tests. The opposite is true for the 15% 
hybrid load, which had one of the lowest masses in the test and still came out with one 
of the biggest antibacterial halos observed. 
Due to the marked difference in release rate between the hybrid load 
membranes, it would be worth manufacturing a second 10% hybrid load membrane as it 
would likely show an intermediate release pattern, and therefore possibly the best 
solution for the three week release period. 
Owing to the results obtained for the nitrogen adsorption/desorption tests, it is 
safe to assume that a higher quantity of GS can be encapsulated into the MSN particles. 
This can be achieved by increasing the concentration of the drug in the impregnation 
solution, this being the most direct and obvious solution. However another way to 
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achieve a higher drug content in the MSN’s is to control the pH levels, specifically, it 
has been proven that having the solution pH at 7, the drug loading can be substantially 
increased [41]. The increased quantity of GS into the MSN could potentially increase 
the release rate of the MSN loaded membranes, without reaching the rates seen on the 
membranes without silica or increase the release window length. 
Another step to be taken is to develop strategies to counteract the MSN 
aggregation verified, thus obtaining a more uniform distribution of MSN particles 
throughout the fibers. In order to achieve this objective the surface of the MSN could be 
chemically modified to increase its hydrophobicity, thus increasing their affinity with 
the polymers in use. 
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Annex A 
Annex A  
 
Sample %mass lost (pm) %mass remaining (mr) 
np-Si 0 100 
GS 74,8 25,2 
npSi-GS 22,0 78,0 
 
Remaining mass of silica nanoparticles in function of initial silica mass: 
 
mr(np-Si)= 1*m(np-Si) 
 
Remaining GS mass in function of initial GS mass: 
 
mrGS= 0,252*mGS 
 
Considering 100g of npSi-GS: 
 
 m(npSi-GS) = mGS + m(npSi) =100  m(np-Si) = 100-mGS   
 
Remaining mass in the GS loaded MSN’s: 
 
 mr(npSi-GS)= mrGS + m(npSi) 
 78 = 0,252mGS + (100 – mGS)  
 78-100 = 0,252mGS –mGS 
 mGS = 29,4 g  
 
%GS loading in MSN’s: 
 
 %(mGS/m(npSi-GS))*100= (29,4/100)*100  ≈ 30% 
 
